Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase EARLY_PHASE1 2Phase 1/2 2Phase 1 2Phase NA 1Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 34Other hematologic neoplasm 5Myeloid 1CNS 1

Conditions

Lymphoma 1Central Nervous System Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 52Radiosurgery 38Radiotherapy 24Blood Specimen Collection 21Magnetic Resonance Imaging 17Bevacizumab 16Temozolomide 13Radiation 12Proton Therapy 10Specimen Handling 9Radiotherapy, Intensity-Modulated 9Mental Status and Dementia Tests 9Carboplatin 9Surgical Procedures, Operative 8Exercise 8Dexmedetomidine 8Vincristine 7Surveys and Questionnaires 7Spinal Puncture 7Etoposide 7Drug Therapy 7Biopsy 7Saline Solution 6Diffusion Tensor Imaging 6Dexamethasone 6Cyclophosphamide 6Therapeutics 5Standard of Care 5Restraint, Physical 5Propofol 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Rituximab × CNS × Clear all
NCT00416819 2015-08-20

Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

University of California, San Francisco

Phase NA Completed
10 enrolled
CNSLymphoid

Lymphoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡